MFW
ENZ

Meristem Family Wealth’s Enzo Biochem, Inc. ENZ Stock Holding History

Meristem Family Wealth’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-10,926
Closed -$49K – 116
2015
Q4 		$49K Hold
10,926
– – 0.02% 113
2015
Q3 		$35K Buy
+10,926
New +$33.2K 0.02% 56

Other funds holding ENZ

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
LSVM
Lone Star Value Management Old Greenwich, Connecticut $52.7M AUM 30.18% 1-Year Est. Return

Meristem Family Wealth's ENZ Position: Q1 2016 in Review

Meristem Family Wealth sold out of Enzo Biochem, Inc. (ENZ) in Q1 2016, closing a stake of 10,926 shares — an estimated $49K sold.

Meristem Family Wealth first reported a position in ENZ in Q3 2015 and held it in 2 quarters. The position peaked at $49K in Q4 2015. 99 funds tracked by Wall St. Rank hold ENZ as of Q1 2016.

  • Meristem Family Wealth reported no remaining Enzo Biochem, Inc. position as of Q1 2016 after selling out during the quarter.
  • Meristem Family Wealth sold 10,926 Enzo Biochem, Inc. shares in Q1 2016, an estimated $49K.
  • Meristem Family Wealth first reported a position in Enzo Biochem, Inc. in Q3 2015 and held it in 2 quarters.
  • Meristem Family Wealth's Enzo Biochem, Inc. position peaked at $49K in Q4 2015.
  • 99 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2016.

Based on Meristem Family Wealth's 13F filing for Q1 2016, filed 27 Apr 2016.